The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Open accessAbstract
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by keeping the cell death effectors, BAX and BAK, in check. The BH3-only proteins initiate apoptosis by neutralizing the pro-survival BCL-2 proteins. Structural analysis and medicinal chemistry led to the development of small-molecule drugs that mimic the function of the BH3-only proteins to kill cancer cells. The BCL-2 inhibitor venetoclax has been approved for treatment of refractory chronic lymphocytic leukemia and this drug and inhibitors of pro-survival MCL-1 and BCL-XL are being tested in diverse malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
Self-citationABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Self-citationPUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Roberts, A. W., Davids, M. S., Pagel, J. M., Kahl, B. S., Puvvada, S. D., Gerecitano, J. F., Kipps, T. J., Anderson, M. A., Brown, J. R., Gressick, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513257 · Cited by 1,900
Self-citationTsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
Veis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
Certo, M., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., & Letai, A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,288
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationKantarjian, H. M., Thomas, X. G., Dmoszynska, A., Wierzbowska, A., Mazur, G., Mayer, J., Gau, J.-P., Chou, W.-C., Buckstein, R., Cermak, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9429 · Cited by 1,169
Dombret, H., Seymour, J. F., Butrym, A., Wierzbowska, A., Selleslag, D., Jang, J. H., Kumar, R., Cavenagh, J., Schuh, A. C., Candoni, A., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621664 · Cited by 1,165
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Konopleva, M., Pollyea, D. A., Potluri, J., Chyla, B., Hogdal, L., Busman, T., McKeegan, E., Salem, A. H., Zhu, M., Ricker, J. L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0313 · Cited by 1,064
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Kotschy, A., Szlavik, Z., Murray, J., Davidson, J., Maragno, A. L., Le Toumelin-Braizat, G., Chanrion, M., Kelly, G. L., Gong, J.-N., Moujalled, D. M., et al. (2016) · Nature · doi:10.1038/nature19830 · Cited by 1,047
Self-citationProgrammed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031
Self-citationKonopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Hitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Seymour, J. F., Kipps, T. J., Eichhorst, B., Hillmen, P., D’Rozario, J., Assouline, S., Owen, C., Gerecitano, J., Robak, T., De la Serna, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713976 · Cited by 940
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Ashkenazi, A., Fairbrother, W. J., Leverson, J. D., & Souers, A. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.253 · Cited by 903
Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876
Bcl-2 family members: Dual regulators of apoptosis and autophagy
Levine, B., Sinha, S. C., & Kroemer, G. (2008) · Autophagy · doi:10.4161/auto.6260 · Cited by 834
Roberts, A. W., Seymour, J. F., Brown, J. R., Wierda, W. G., Kipps, T. J., Khaw, S. L., Carney, D. A., He, S. Z., Huang, D. C. S., Xiong, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7898 · Cited by 830
Self-citationStilgenbauer, S., Eichhorst, B., Schetelig, J., Coutre, S., Seymour, J. F., Munir, T., Puvvada, S. D., Wendtner, C.-M., Roberts, A. W., Jurczak, W., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30019-5 · Cited by 805
Self-citationDevelopment and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Davids, M. S., Roberts, A. W., Seymour, J. F., Pagel, J. M., Kahl, B. S., Wierda, W. G., Puvvada, S., Kipps, T. J., Anderson, M. A., Salem, A. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.4320 · Cited by 748
Self-citationDiNardo, C. D., Pratz, K. W., Letai, A., Jonas, B. A., Wei, A. H., Thirman, M., Arellano, M., Frattini, M. G., Kantarjian, H., Popovic, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30010-x · Cited by 722
Self-citationMOMP, cell suicide as a BCL-2 family business
Kalkavan, H., & Green, D. R. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.179 · Cited by 664
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Niederst, M. J., Sequist, L. V., Poirier, J. T., Mermel, C. H., Lockerman, E. L., Garcia, A. R., Katayama, R., Costa, C., Ross, K. N., Moran, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7377 · Cited by 647
BCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
Self-citationGandhi, L., Camidge, D. R., Ribeiro de Oliveira, M., Bonomi, P., Gandara, D., Khaira, D., Hann, C. L., McKeegan, E. M., Litvinovich, E., Hemken, P. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6208 · Cited by 603
Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells
Opferman, J. T., Iwasaki, H., Ong, C. C., Suh, H., Mizuno, S.-I., Akashi, K., & Korsmeyer, S. J. (2005) · Science · doi:10.1126/science.1106114 · Cited by 574
Rudin, C. M., Hann, C. L., Garon, E. B., Ribeiro de Oliveira, M., Bonomi, P. D., Camidge, D. R., Chu, Q., Giaccone, G., Khaira, D., Ramalingam, S. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3090 · Cited by 564
Leverson, J. D., Phillips, D. C., Mitten, M. J., Boghaert, E. R., Diaz, D., Tahir, S. K., Belmont, L. D., Nimmer, P., Xiao, Y., Ma, X. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4642 · Cited by 541
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Adams, J. M., & Cory, S. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.161 · Cited by 530
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Kumar, S., Kaufman, J. L., Gasparetto, C., Mikhael, J., Vij, R., Pegourie, B., Benboubker, L., Facon, T., Amiot, M., Moreau, P., et al. (2017) · Blood · doi:10.1182/blood-2017-06-788786 · Cited by 523
BCL2 family in DNA damage and cell cycle control
Zinkel, S., Gross, A., & Yang, E. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401987 · Cited by 474
Leverson, J. D., Zhang, H., Chen, J., Tahir, S. K., Phillips, D. C., Xue, J., Nimmer, P., Jin, S., Smith, M., Xiao, Y., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.561 · Cited by 440
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Tam, C. S., Anderson, M. A., Pott, C., Agarwal, R., Handunnetti, S., Hicks, R. J., Burbury, K., Turner, G., Di Iulio, J., Bressel, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715519 · Cited by 433
Self-citationCaenepeel, S., Brown, S. P., Belmontes, B., Moody, G., Keegan, K. S., Chui, D., Whittington, D. A., Huang, X., Poppe, L., Cheng, A. C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0387 · Cited by 432
Self-citationDiNardo, C. D., Rausch, C. R., Benton, C., Kadia, T., Jain, N., Pemmaraju, N., Daver, N., Covert, W., Marx, K. R., Mace, M., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25000 · Cited by 424
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Glaser, S. P., Lee, E. F., Trounson, E., Bouillet, P., Wei, A., Fairlie, W. D., Izon, D. J., Zuber, J., Rappaport, A. R., Herold, M. J., et al. (2012) · Genes & Development · doi:10.1101/gad.182980.111 · Cited by 423
Self-citationPerciavalle, R. M., Stewart, D. P., Koss, B., Lynch, J., Milasta, S., Bathina, M., Temirov, J., Cleland, M. M., Pelletier, S., Schuetz, J. D., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2488 · Cited by 410
Chen, R., Valencia, I., Zhong, F., McColl, K. S., Roderick, H. L., Bootman, M. D., Berridge, M. J., Conway, S. J., Holmes, A. B., Mignery, G. A., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309146 · Cited by 404
Aubrey, B. J., Kelly, G. L., Kueh, A. J., Brennan, M. S., O’Connor, L., Milla, L., Wilcox, S., Tai, L., Strasser, A., & Herold, M. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.002 · Cited by 399
Self-citationMcl-1 deficiency results in peri-implantation embryonic lethality
Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.1.23 · Cited by 397
Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice
Nakayama, K.-I., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., et al. (1993) · Science · doi:10.1126/science.8372353 · Cited by 397
Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., & Loh, D. Y. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3700 · Cited by 395
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Muranen, T., Selfors, L. M., Worster, D. T., Iwanicki, M. P., Song, L., Morales, F. C., Gao, S., Mills, G. B., & Brugge, J. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.024 · Cited by 384
Structure-guided design of a selective BCL-XL inhibitor
Lessene, G., Czabotar, P. E., Sleebs, B. E., Zobel, K., Lowes, K. N., Adams, J. M., Baell, J. B., Colman, P. M., Deshayes, K., Fairbrother, W. J., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1246 · Cited by 381
Self-citationRamsey, H. E., Fischer, M. A., Lee, T., Gorska, A. E., Arrate, M. P., Fuller, L., Boyd, K. L., Strickland, S. A., Sensintaffar, J., Hogdal, L. J., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0140 · Cited by 379
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Yecies, D., Carlson, N. E., Deng, J., & Letai, A. (2010) · Blood · doi:10.1182/blood-2009-07-233304 · Cited by 360
Vo, T.-T., Ryan, J., Carrasco, R., Neuberg, D., Rossi, D. J., Stone, R. M., DeAngelo, D. J., Frattini, M. G., & Letai, A. (2012) · Cell · doi:10.1016/j.cell.2012.08.038 · Cited by 348
Cragg, M. S., Kuroda, J., Puthalakath, H., Huang, D. C. S., & Strasser, A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040316 · Cited by 343
Self-citationDel Poeta, G., Venditti, A., Del Principe, M. I., Maurillo, L., Buccisano, F., Tamburini, A., Cox, M. C., Franchi, A., Bruno, A., Mazzone, C., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1714 · Cited by 340
Kuroda, J., Puthalakath, H., Cragg, M. S., Kelly, P. N., Bouillet, P., Huang, D. C. S., Kimura, S., Ottmann, O. G., Druker, B. J., Villunger, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606176103 · Cited by 336
Self-citationApoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant
Print, C. G., Loveland, K. L., Gibson, L., Meehan, T., Stylianou, A., Wreford, N., de Kretser, D., Metcalf, D., Köntgen, F., Adams, J. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12424 · Cited by 335
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
Seymour, J. F., Ma, S., Brander, D. M., Choi, M. Y., Barrientos, J., Davids, M. S., Anderson, M. A., Beaven, A. W., Rosen, S. T., Tam, C. S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30012-8 · Cited by 333
Self-citationWhy do BCL-2 inhibitors work and where should we use them in the clinic?
Montero, J., & Letai, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.183 · Cited by 327
O'Neill, K. L., Huang, K., Zhang, J., Chen, Y., & Luo, X. (2016) · Genes & Development · doi:10.1101/gad.276725.115 · Cited by 323
Vogler, M., Butterworth, M., Majid, A., Walewska, R. J., Sun, X.-M., Dyer, M. J. S., & Cohen, G. M. (2009) · Blood · doi:10.1182/blood-2008-08-173310 · Cited by 323
Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis
Hershko, T., & Ginsberg, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312866200 · Cited by 322
Mcl-1 is essential for the survival of plasma cells
Peperzak, V., Vikström, I., Walker, J., Glaser, S. P., LePage, M., Coquery, C. M., Erickson, L. D., Fairfax, K., Mackay, F., Strasser, A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2527 · Cited by 320
Self-citationDawson, S.-J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605736 · Cited by 317
Anderson, M. A., Deng, J., Seymour, J. F., Tam, C., Kim, S. Y., Fein, J., Yu, L., Brown, J. R., Westerman, D., Si, E. G., et al. (2016) · Blood · doi:10.1182/blood-2016-01-688796 · Cited by 316
Self-citationStilgenbauer, S., Eichhorst, B., Schetelig, J., Hillmen, P., Seymour, J. F., Coutre, S., Jurczak, W., Mulligan, S. P., Schuh, A., Assouline, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.6840 · Cited by 314
Self-citationDiscovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity
Tao, Z.-F., Hasvold, L., Wang, L., Wang, X., Petros, A. M., Park, C. H., Boghaert, E. R., Catron, N. D., Chen, J., Colman, P. M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5001867 · Cited by 309
Self-citationPunnoose, E. A., Leverson, J. D., Peale, F., Boghaert, E. R., Belmont, L. D., Tan, N., Young, A., Mitten, M., Ingalla, E., Darbonne, W. C., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0730 · Cited by 305
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.
Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J., & Nuñez, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06307.x · Cited by 301
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
Touzeau, C., Dousset, C., Le Gouill, S., Sampath, D., Leverson, J. D., Souers, A. J., Maïga, S., Béné, M. C., Moreau, P., Pellat-Deceunynck, C., et al. (2014) · Leukemia · doi:10.1038/leu.2013.216 · Cited by 289
The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages
Dzhagalov, I., St. John, A., & He, Y.-W. (2007) · Blood · doi:10.1182/blood-2006-03-013771 · Cited by 279
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Wang, X., Bathina, M., Lynch, J., Koss, B., Calabrese, C., Frase, S., Schuetz, J. D., Rehg, J. E., & Opferman, J. T. (2013) · Genes & Development · doi:10.1101/gad.215855.113 · Cited by 279
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Vaillant, F., Merino, D., Lee, L., Breslin, K., Pal, B., Ritchie, M. E., Smyth, G. K., Christie, M., Phillipson, L. J., Burns, C. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.002 · Cited by 276
Self-citationDegenerative Disorders Caused by Bcl-2 Deficiency Prevented by Loss of Its BH3-Only Antagonist Bim
Bouillet, P., Cory, S., Zhang, L.-C., Strasser, A., & Adams, J. M. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00083-1 · Cited by 274
Self-citationbcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells
Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezzella, F., Pierotti, M., & Della Porta, G. (1992) · Blood · doi:10.1182/blood.v79.5.1291.1291 · Cited by 274
Yoshimoto, G., Miyamoto, T., Jabbarzadeh-Tabrizi, S., Iino, T., Rocnik, J. L., Kikushige, Y., Mori, Y., Shima, T., Iwasaki, H., Takenaka, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-196055 · Cited by 272
Moreau, P., Chanan-Khan, A., Roberts, A. W., Agarwal, A. B., Facon, T., Kumar, S., Touzeau, C., Punnoose, E. A., Cordero, J., Munasinghe, W., et al. (2017) · Blood · doi:10.1182/blood-2017-06-788323 · Cited by 271
Self-citationTesticular degeneration in Bclw-deficient mice
Ross, A. J., Waymire, K. G., Moss, J. E., Parlow, A. F., Skinner, M. K., Russell, L. D., & MacGregor, G. R. (1998) · Nature Genetics · doi:10.1038/ng0398-251 · Cited by 269
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
Thomas, R. L., Roberts, D. J., Kubli, D. A., Lee, Y., Quinsay, M. N., Owens, J. B., Fischer, K. M., Sussman, M. A., Miyamoto, S., & Gustafsson, Å. B. (2013) · Genes & Development · doi:10.1101/gad.215871.113 · Cited by 269
Aldoss, I., Yang, D., Aribi, A., Ali, H., Sandhu, K., Al Malki, M. M., Mei, M., Salhotra, A., Khaled, S., Nakamura, R., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.188094 · Cited by 269
Huntington, N. D., Puthalakath, H., Gunn, P., Naik, E., Michalak, E. M., Smyth, M. J., Tabarias, H., Degli-Esposti, M. A., Dewson, G., Willis, S. N., et al. (2007) · Nature Immunology · doi:10.1038/ni1487 · Cited by 268
Self-citationAn interconnected hierarchical model of cell death regulation by the BCL-2 family
Chen, H.-C., Kanai, M., Inoue-Yamauchi, A., Tu, H.-C., Huang, Y., Ren, D., Kim, H., Takeda, S., Reyna, D. E., Chan, P. M., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3236 · Cited by 249
Niu, X., Zhao, J., Ma, J., Xie, C., Edwards, H., Wang, G., Caldwell, J. T., Xiang, S., Zhang, X., Chu, R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3057 · Cited by 248
Bclx regulates the survival of double-positive thymocytes.
Ma, A., Pena, J. C., Chang, B., Margosian, E., Davidson, L., Alt, F. W., & Thompson, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4763 · Cited by 244
Erlacher, M., Labi, V., Manzl, C., Böck, G., Tzankov, A., Häcker, G., Michalak, E., Strasser, A., & Villunger, A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061552 · Cited by 233
Self-citationExpression of bcl-2 in small cell lung carcinoma cells.
Ikegaki, N., Katsumata, M., Minna, J. D., & Tsujimoto, Y. (1994) · PubMed · Cited by 220
Song, L., Coppola, D., Livingston, S., Cress, W. D., & Haura, E. B. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.3.1496 · Cited by 215
Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
Vikstrom, I., Carotta, S., Lüthje, K., Peperzak, V., Jost, P. J., Glaser, S., Busslinger, M., Bouillet, P., Strasser, A., Nutt, S. L., et al. (2010) · Science · doi:10.1126/science.1191793 · Cited by 215
Self-citationBlastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Montero, J., Stephansky, J., Cai, T., Griffin, G. K., Cabal-Hierro, L., Togami, K., Hogdal, L. J., Galinsky, I., Morgan, E. A., Aster, J. C., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0999 · Cited by 212
Cragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., & Scott, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35437 · Cited by 207
Self-citationBogenberger, J. M., Kornblau, S. M., Pierceall, W. E., Lena, R., Chow, D., Shi, C.-X., Mantei, J., Ahmann, G., Gonzales, I. M., Choudhary, A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.44 · Cited by 200
Potential mechanisms of resistance to venetoclax and strategies to circumvent it
Tahir, S. K., Smith, M. L., Hessler, P., Rapp, L. R., Idler, K. B., Park, C. H., Leverson, J. D., & Lam, L. T. (2017) · BMC Cancer · doi:10.1186/s12885-017-3383-5 · Cited by 195
Mcl-1 Is a Key Regulator of Apoptosis during CNS Development and after DNA Damage
Arbour, N., Vanderluit, J. L., Le Grand, J. N., Jahani-Asl, A., Ruzhynsky, V. A., Cheung, E. C. C., Kelly, M. A., MacKenzie, A. E., Park, D. S., Opferman, J. T., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4940-07.2008 · Cited by 194
Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Oakes, S. R., Vaillant, F., Lim, E., Lee, L., Breslin, K., Feleppa, F., Deb, S., Ritchie, M. E., Takano, E., Ward, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104778108 · Cited by 193
Self-citationMérino, D., Khaw, S. L., Glaser, S. P., Anderson, D. J., Belmont, L. D., Wong, C., Yue, P., Robati, M., Phipson, B., Fairlie, W. D., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400929 · Cited by 192
Self-citationProsurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak
Lindqvist, L. M., Heinlein, M., Huang, D. C. S., & Vaux, D. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406425111 · Cited by 190
Fresquet, V., Rieger, M., Carolis, C., García-Barchino, M. J., & Martinez-Climent, J. A. (2014) · Blood · doi:10.1182/blood-2014-03-560284 · Cited by 188
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
Sathe, P., Delconte, R. B., Souza-Fonseca-Guimaraes, F., Seillet, C., Chopin, M., Vandenberg, C. J., Rankin, L. C., Mielke, L. A., Vikstrom, I., Kolesnik, T. B., et al. (2014) · Nature Communications · doi:10.1038/ncomms5539 · Cited by 187
Self-citationUnleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Cragg, M. S., Harris, C., Strasser, A., & Scott, C. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2615 · Cited by 185
Self-citationMerino, D., Whittle, J. R., Vaillant, F., Serrano, A., Gong, J.-N., Giner, G., Maragno, A. L., Chanrion, M., Schneider, E., Pal, B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7049 · Cited by 185
Self-citationVenetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
Khaw, S. L., Suryani, S., Evans, K., Richmond, J., Robbins, A., Kurmasheva, R. T., Billups, C. A., Erickson, S. W., Guo, Y., Houghton, P. J., et al. (2016) · Blood · doi:10.1182/blood-2016-03-707414 · Cited by 174
Self-citationMoujalled, D. M., Pomilio, G., Ghiurau, C., Ivey, A., Salmon, J., Rijal, S., Macraild, S., Zhang, L., Teh, T.-C., Tiong, I.-S., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0261-3 · Cited by 174
Self-citationTargeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Inoue-Yamauchi, A., Jeng, P. S., Kim, K., Chen, H.-C., Han, S., Ganesan, Y. T., Ishizawa, K., Jebiwott, S., Dong, Y., Pietanza, M. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms16078 · Cited by 173
Konopleva, M., Zhao, S., Hu, W., Jiang, S., Snell, V., Weidner, D., Jackson, C. E., Zhang, X., Champlin, R., Estey, E., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03637.x · Cited by 171
Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas
Jiang, S., Sato, Y., Kuwao, S., & Kameya, T. (1995) · The Journal of Pathology · doi:10.1002/path.1711770206 · Cited by 166
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
Kelly, G. L., Grabow, S., Glaser, S. P., Fitzsimmons, L., Aubrey, B. J., Okamoto, T., Valente, L. J., Robati, M., Tai, L., Fairlie, W. D., et al. (2014) · Genes & Development · doi:10.1101/gad.232009.113 · Cited by 166
Self-citationVick, B., Weber, A., Urbanik, T., Maass, T., Teufel, A., Krammer, P. H., Opferman, J. T., Schuchmann, M., Galle, P. R., & Schulze‐Bergkamen, H. (2008) · Hepatology · doi:10.1002/hep.22664 · Cited by 165
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
Zhang, H., Guttikonda, S., Roberts, L., Uziel, T., Semizarov, D., Elmore, S. W., Leverson, J. D., & Lam, L. T. (2011) · Oncogene · doi:10.1038/onc.2010.559 · Cited by 164
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer
Merino, D., Lok, S. W., Visvader, J. E., & Lindeman, G. J. (2016) · Oncogene · doi:10.1038/onc.2015.287 · Cited by 161
Self-citationChromosome 14 translocations in non‐burkitt lymphomas
Fukuhara, S., & Rowley, J. D. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910220105 · Cited by 161
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
Teh, T.-C., Nguyen, N.-Y., Moujalled, D. M., Segal, D., Pomilio, G., Rijal, S., Jabbour, A., Cummins, K., Lackovic, K., Blombery, P., et al. (2018) · Leukemia · doi:10.1038/leu.2017.243 · Cited by 159
Self-citationHierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1
Gong, J.-N., Khong, T. T., Segal, D., Yao, Y., Riffkin, C. D., Garnier, J.-M., Khaw, S. L., Lessène, G., Spencer, A. G., Herold, M. J., et al. (2016) · Blood · doi:10.1182/blood-2016-03-704908 · Cited by 156
Self-citationMorales, A. A., Kurtoğlu, M., Matulis, S. M., Liu, J., Siefker, D. T., Gutman, D. M., Kaufman, J. L., Lee, K. P., Lonial, S., & Boise, L. (2011) · Blood · doi:10.1182/blood-2011-01-327197 · Cited by 138
Ham, J., Costa, C., Sano, R., Lochmann, T. L., Sennott, E. M., Patel, N. U., Dastur, A., Gomez‐Caraballo, M., Krytska, K., Hata, A. N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.002 · Cited by 138
bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
Gratiot-Deans, J., Ding, L., Turka, L. A., & Núñez, G. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.83 · Cited by 135
PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis
Bean, G. R., Ganesan, Y. T., Dong, Y., Takeda, S., Liu, H., Chan, P. M., Huang, Y., Chodosh, L. A., Zambetti, G. P., Hsieh, J. J.-D., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003483 · Cited by 130
Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML
Wei, A. H., & Tiong, I. S. (2017) · Blood · doi:10.1182/blood-2017-08-784066 · Cited by 130
Self-citationXiao, Y., Nimmer, P. M., Sheppard, G. S., Bruncko, M., Hessler, P., Lu, X. L., Roberts-Rapp, L. A., Pappano, W. N., Elmore, S. W., Souers, A. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0928 · Cited by 128
Faber, A. C., Coffee, E. M., Costa, C., Dastur, A., Ebi, H., Hata, A. N., Yeo, A. T., Edelman, E. J., Song, Y., Tam, A. T., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0315 · Cited by 124
Happo, L., Cragg, M. S., Phipson, B., Haga, J. M., Jansen, E. S., Herold, M. J., Dewson, G., Michalak, E. M., Vandenberg, C. J., Smyth, G. K., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280818 · Cited by 112
Self-citationThe Essential Role of Evasion from Cell Death in Cancer
Kelly, G. L., & Strasser, A. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00002-7 · Cited by 111
Self-citationKoss, B. S., Morrison, J. B., Perciavalle, R. M., Singh, H., Rehg, J. E., Williams, R. T., & Opferman, J. T. (2013) · Blood · doi:10.1182/blood-2012-06-440230 · Cited by 97
Brennan, M. S., Chang, C. W. T., Dewson, G., Tai, L., Lessène, G., Strasser, A., Kelly, G. L., & Herold, M. J. (2018) · Blood · doi:10.1182/blood-2018-06-859405 · Cited by 95
Self-citationNangia, V., Siddiqui, F. M., Caenepeel, S., Timonina, D., Bilton, S. J., Phan, N., Gomez-Caraballo, M., Archibald, H. L., Li, C., Fraser, C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0277 · Cited by 94
Zhao, X., Bodo, J., Sun, D., Durkin, L. M., Lin, J. J., Smith, M. R., & Hsi, E. D. (2014) · British Journal of Haematology · doi:10.1111/bjh.13149 · Cited by 93
Khaw, S. L., Mérino, D., Anderson, M. A., Glaser, S. P., Bouillet, P., Roberts, A. W., & Huang, D. C. S. (2014) · Leukemia · doi:10.1038/leu.2014.1 · Cited by 93
Self-citationWeeden, C. E., Ah-Cann, C., Holik, A. Z., Pasquet, J., Garnier, J.-M., Mérino, D., Lessène, G., & Asselin-Labat, M.-L. (2018) · Oncogene · doi:10.1038/s41388-018-0268-2 · Cited by 92
Rooswinkel, R. W., van de Kooij, B., Verheij, M., & Borst, J. G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.109 · Cited by 91
Spermatogenesis in Bclw-Deficient Mice1
Russell, L. D., Warren, J., Debéljuk, L., Richardson, L. L., Mahar, P. L., Waymire, K. G., Amy, S. P., Ross, A. J., & MacGregor, G. R. (2001) · Biology of Reproduction · doi:10.1095/biolreprod65.1.318 · Cited by 84
Young, A. I. J., Law, A. M. K., Castillo, L. E., Chong, S., Cullen, H., Koehler, M., Herzog, S., Brummer, T., Lee, E. F., Fairlie, W. D., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0781-6 · Cited by 84
EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival
Fu, N. Y., Rios, A. C., Pal, B., Soetanto, R., Lun, A. T. L., Liu, K., Beck, T. J., Best, S. A., Vaillant, F., Bouillet, P., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3117 · Cited by 83
Self-citationBax/Bak activation in the absence of Bid, Bim, Puma, and p53
Zhang, J., Huang, K., O’Neill, K. L., Pang, X., & Luo, X. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.167 · Cited by 80
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Boidol, B., Kornauth, C., van der Kouwe, E., Prutsch, N., Kazianka, L., Gültekin, S., Hoermann, G., Mayerhoefer, M. E., Hopfinger, G., Hauswirth, A. W., et al. (2017) · Blood · doi:10.1182/blood-2017-05-785683 · Cited by 73
Bcl-2 binds to and inhibits ryanodine receptors
Vervliet, T., Decrock, E., Molgó, J., Sorrentino, V., Missiaen, L., Leybaert, L., SMEDT, H. D., Kasri, N. N., Parys, J. B., & Bultynck, G. (2014) · Journal of Cell Science · doi:10.1242/jcs.150011 · Cited by 72
de Vos, S., Swinnen, L. J., Wang, D. D., Reid, E. G., Fowler, N., Cordero, J., Dunbar, M., Enschede, S. H., Nolan, C. E., Petrich, A. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy256 · Cited by 71
Accelerated disappearance of melanocytes in bcl-2-deficient mice.
Yamamura, K., Kamada, S., Ito, S., Nakagawa, K., Ichihashi, M., & Tsujimoto, Y. (1996) · PubMed · Cited by 66
Bate-Eya, L. T., den Hartog, I. J. M., van der Ploeg, I., Schild, L. G., Köster, J., Santo, E. E., Westerhout, E. M., Versteeg, R., Caron, H. N., Molenaar, J. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8547 · Cited by 63
Wei, A. H., Strickland, S. A., Roboz, G. J., Hou, J., Fiedler, W., Lin, T. L., Walter, R. B., Enjeti, A. K., Chyla, B., Popovic, R., et al. (2017) · Blood · doi:10.1182/blood.v130.suppl_1.890.890 · Cited by 58
Self-citationBim and Bcl-2 Mutually Affect the Expression of the Other in T Cells
Jørgensen, T. N., McKee, A. S., Wang, M., Kushnir, E., White, J., Refaeli, Y., Kappler, J. W., & Marrack, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3417 · Cited by 51
Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
Karpel‐Massler, G., Ishida, C. T., Zhang, Y., Halatsch, M., Westhoff, M., & Siegelin, M. D. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1356286 · Cited by 49
A Novel Role for Bcl-2 in Regulation of Cellular Calcium Extrusion
Ferdek, P. E., Gerasimenko, J. V., Peng, S., Tepikin, A. V., Petersen, O. H., & Gerasimenko, O. V. (2012) · Current Biology · doi:10.1016/j.cub.2012.05.002 · Cited by 48
Kasai, S., Chuma, S., Motoyama, N., & Nakatsuji, N. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00400-7 · Cited by 47
Grabow, S., Delbridge, A. R. D., Valente, L. J., & Strasser, A. (2014) · Blood · doi:10.1182/blood-2014-09-601567 · Cited by 45
Self-citationValente, L. J., Aubrey, B. J., Herold, M. J., Kelly, G. L., Happo, L., Scott, C. L., Newbold, A., Johnstone, R. W., Huang, D. C. S., Vassilev, L. T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.059 · Cited by 40
Self-citationA critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice
Jain, R., Sheridan, J. M., Policheni, A. N., Heinlein, M., Gandolfo, L. C., Dewson, G., Smyth, G. K., Sansom, S. N., Fu, N. Y., Visvader, J. E., et al. (2017) · Blood · doi:10.1182/blood-2017-03-771576 · Cited by 40
Self-citationSelect Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma
Tanos, R., Karmali, D., Nalluri, S., & Goldsmith, K. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2129-0 · Cited by 39
Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC
Potter, D. S., Galvin, M., Brown, S., Lallo, A., Hodgkinson, C. L., Blackhall, F. H., Morrow, C. J., & Dive, C. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0885 · Cited by 38
Delbridge, A. R. D., Opferman, J. T., Grabow, S., & Strasser, A. (2015) · Blood · doi:10.1182/blood-2015-01-621250 · Cited by 35
Self-citationRe-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
Spinner, S., Crispatzu, G., Yi, J.-H., Munkhbaatar, E., Mayer, P., Höckendorf, U., Müller, N., Li, Z., Schader, T., Bendz, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.49 · Cited by 35
Self-citationKim, E. Y., Jung, J. Y., Kim, A., Chang, Y. S., & Kim, S. I. (2017) · Neoplasia · doi:10.1016/j.neo.2017.02.008 · Cited by 35
Panayotopoulou, E. G., Müller, A., Börries, M., Busch, H. S., Hu, G., & Lev, S. (2017) · Oncotarget · doi:10.18632/oncotarget.15125 · Cited by 29
The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice
Brinkmann, K., Grabow, S., Hyland, C. D., Teh, C. E., Alexander, W. S., Herold, M. J., & Strasser, A. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.125 · Cited by 29
Self-citationRohrbeck, L., Gong, J., Lee, E. F., Kueh, A. J., Behren, A., Tai, L., Lessène, G., Huang, D. C. S., Fairlie, W. D., Strasser, A., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.96 · Cited by 27
Self-citationBim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression
Mérino, D., Strasser, A., & Bouillet, P. (2011) · Oncogene · doi:10.1038/onc.2011.508 · Cited by 26
Self-citationHird, A. W., Secrist, J. P., Adam, A., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-ddt01-02 · Cited by 22
Lindeman, G. J., Lok, S. W., Bergin, A. R. T., Whittle, J. R., Shackleton, K., Sherman, P., Dawson, S., Desai, J., Liew, D., Mann, G. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.1044 · Cited by 10
Self-citation
Cited by
Mitochondria as multifaceted regulators of cell death
Bock, F. J., & Tait, S. W. G. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0173-8 · Cited by 2,450
Emerging connectivity of programmed cell death pathways and its physiological implications
Bedoui, S., Herold, M. J., & Strasser, A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0270-8 · Cited by 979
Self-citationNedeljković, M., & Damjanović, A. (2019) · Cells · doi:10.3390/cells8090957 · Cited by 870
Mitochondria as playmakers of apoptosis, autophagy and senescence
Abate, M., Festa, A., Falco, M., Lombardi, A., Luce, A., Grimaldi, A., Zappavigna, S., Sperlongano, P., Irace, C., Caraglia, M., et al. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.022 · Cited by 545
BCL-2 protein family: attractive targets for cancer therapy
Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L. (2023) · Apoptosis · doi:10.1007/s10495-022-01780-7 · Cited by 500
Self-citation
Metadata
- Authors
- Merino, D., Kelly, G. L., Lessene, G., Wei, A. H., Roberts, A. W., & Strasser, A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 34
- Issue
- 6
- Pages
- 879-891
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2904016068
- Cited by
- 287
- References
- 160
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.